Weight loss drug ‘Ozempic’ approved for use in India: What we need to know about its health benefits and risks
India has officially approved the use of Ozempic (semaglutide), a once-a-week injection designed for adults with type 2 diabetes. Approved by the Central Drugs Standard Control Organisation (CDSCO), this drug…
AP Gets First Notified Body for Medical Device Manufacturing Facilities Inspection
CDSCO has notified KIHT Certification Services (KCS) inside AMTZ as state’s first regulatory body Visakhapatnam: Andhra Pradesh is now home to its first-ever CDSCO notified auditing body for medical devices.…
Glenmark Pharma launches TEVIMBRA in India
Glenmark Pharmaceuticals announced that it had launched TEVIMBRA (tislelizumab) in India after receiving approval from the Central Drugs Standard Control Organization (CDSCO). The drug is a specially designed anti-PD-1 monoclonal…
Approvals for medical devices may ease with new classification
The Central Drugs Standard Control Organisation’s (CDSCO’s) draft rules for re-classification of medical devices based on their risk profile has received wide support from the industry, as it will allow…
Samples of 27 drugs manufactured in Himachal found substandard
As many as 27 drug samples, manufactured at pharmaceutical units of Himachal Pradesh at Baddi, Nalagarh, Paonta Sahib, Kala Amb, Solan and Kangra, have been declared sub substandard by the…
Govt reviews medical device testing capabilities
New Delhi : The Central Drugs Standard Control Organisation (CDSCO) is reviewing a task force report submitted to the Drugs Controller General of India (DCGI) on laboratories for testing medical…
Action taken against pharma cos following reports of deaths, injuries due to their substandard drugs abroad: Government
The Central Drugs Standard Control Organisation in coordination with state authorities initiated action against pharma companies following reports of deaths and injuries due to their substandard drugs in the Gambia and Uzbekistan,…
Zydus Cadila gets DCGI nod to initiate Phase-3 clinical trials for Covid-19 vaccine
Drug firm Zydus Cadila on Sunday said it has received DCGI approval to initiate Phase III clinical trials of its Covid-19 vaccine ZyCoV-D. The company will now be initiating Phase III clinical trial in…
